Zdrowie i gospodarka · 22/10/2004

Request for Public Comment on FDA's Use of Oral Azithromycin for Chlamydia-Related Pneumonia and Conjunctivitis in Infants

The National Institutes of Health (NIH) is seeking public input on a request from the Food and Drug Administration (FDA) to study the safety and effectiveness of oral azithromycin for treating pneumonia and conjunctivitis in infants caused by Chlamydia Trachomatis.